DFH-12

N/A

Report date: 2025/11/24 17:58:25
NME

Base Information

Drug NameDFH-12
Drug Alias NamePulmoBind99mTC-PulmoBindTc 99m adrenomedullinDFH-12
ClassificationRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Technetium > 99mTcSmall molecules > Synthetic peptide > Peptide drug conjugate (PDC) +[5] 
Mechanisms of ActionAdrenomedullin receptor agonists
TargetsAdrenomedullin receptor
Therapy Area/IndicationsPulmonary EmbolismPulmonary Arterial HypertensionHypertension, Pulmonary
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMontreal Heart Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPulmo BiotechPulmo ScienceMontreal Heart Institute
Active IndicationsN/A
Inactive IndicationsPulmonary EmbolismPulmonary Arterial HypertensionHypertension, Pulmonary

Other Information

ATC CodeN/A
Related LinksN/A